Novel potent SQS inhibitor

Novel CrtM inhibitor

Squalene synthase (SQS) inhibitor, potently inhibiting CrtM

The first potent inhibitor of Burkholderia pseudomallei methionine aminopeptidase

Novel RBP4 antagonist with good in vitro potency and selectivity and optimal rodent pharmacokinetic (PK) and pharmacodynamic (PD) characteristics

Novel potent and selective dual FLT3/AURKA inhibitor

Potent direct PTEN inhibitor

Potent and se;rctive PTEN inhibitor, activating the insulin receptor kinase, inhibiting the dephosphorylation of autophosphorylated insulin receptors and epidermal growth factor receptors of rat liver endosomes

Novel apoptosis signal-regulating kinase 1 (ASK1) inhibitor with IC50 of 0.52μM in vitro in kinase assay

Novel potent inhibitor of human neutrophil activations

Quantity (mg or Unit) Unit Price ($/mg or $/Unit) Final Price 100 $292.50 Total: $29,250.00 50 $338.00 Total: $16,900.00 25 $396.50 Total: $9,912.50 10 $468.00 Total: $4,680.00 5 $552.50 Total: $2,762.50

Monoamine Reuptake Inhibitor

Inhibitor of cyclobrassinin hydrolase, a unique enzyme from the fungal pathogen Alternaria brassicicola

Natural small molecule isolated from dried heartwood of Caesalpinia sappan L, exhibiting multi-pharmacological activities

Novel multistage antimalarial inhibitor

Novel Inhibitor of Clostridium difficile

Novel potent inhibitor of spCas9, disrupting spCas9-DNA binding and exerting dose and temporal control of spCas9 in human cell lines

Novel HDAC inhibitor, inhibiting multiple HDAC enzymes and modulates acetylation levels in cells

Positive control for HSPC toxicity; Inhibitor of STK33

Negative control for tubastatin A

Novel inhibitor of parasite phenylalanyl-tRNA synthetase (PheRS)

Novel non-histone nuclear substrate of histone deacetylase 8 (HDAC8)